Literature DB >> 20078408

Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia.

Justin T Denholm1, Claire L Gordon, Paul D Johnson, Saliya S Hewagama, Rhonda L Stuart, Craig Aboltins, Cameron Jeremiah, James Knox, Garry P Lane, Adrian R Tramontana, Monica A Slavin, Thomas R Schulz, Michael Richards, Chris J Birch, Allen C Cheng.   

Abstract

OBJECTIVE: To describe the case characteristics and outcomes of patients hospitalised with pandemic (H1N1) 2009 influenza infection during the first 2 months of the epidemic. DESIGN, PARTICIPANTS AND
SETTING: Prospective case series of 112 patients admitted to seven hospitals in Melbourne with laboratory-confirmed pandemic (H1N1) 2009 influenza between 1 May and 17 July 2009. MAIN OUTCOME MEASURES: Details of case characteristics, risk factors for severe disease, treatment and clinical course.
RESULTS: Of 112 hospitalised patients, most presented with cough (88%) and/or fever (82%), but several (4%) had neither symptom. A quarter of female patients (15) were pregnant or in the post-partum period. Patients presenting with multifocal changes on chest x-ray had significantly longer hospital lengths of stay, and were more likely to require intensive care unit admission. Thirty patients required admission to an intensive care unit, and three died during their acute illness. The median length of intensive care admission was 10.5 days (interquartile range, 5-16 days).
CONCLUSIONS: This study highlights risk factors for severe disease, particularly pregnancy. Clinical and public health planning for upcoming influenza seasons should take into account the spectrum and severity of clinical infection demonstrated in this report, and the need to concentrate resources effectively in high-risk patient groups.

Entities:  

Mesh:

Year:  2010        PMID: 20078408

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  39 in total

1.  Ibrutinib may impair serological responses to influenza vaccination.

Authors:  Abby P Douglas; Jason A Trubiano; Ian Barr; Vivian Leung; Monica A Slavin; Constantine S Tam
Journal:  Haematologica       Date:  2017-06-28       Impact factor: 9.941

2.  Pandemic (H1N1) 2009 influenza community transmission was established in one Australian state when the virus was first identified in North America.

Authors:  Heath A Kelly; Geoff N Mercer; James E Fielding; Gary K Dowse; Kathryn Glass; Dale Carcione; Kristina A Grant; Paul V Effler; Rosemary A Lester
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

Review 3.  Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic.

Authors:  Charles R Beck; Rachel Sokal; Nachiappan Arunachalam; Richard Puleston; Anna Cichowska; Anthony Kessel; Maria Zambon; Jonathan S Nguyen-Van-Tam
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

Review 4.  Mechanisms of sex disparities in influenza pathogenesis.

Authors:  Sabra L Klein; Andrea Hodgson; Dionne P Robinson
Journal:  J Leukoc Biol       Date:  2011-11-30       Impact factor: 4.962

5.  Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.

Authors:  Stephanie Gras; Lukasz Kedzierski; Sophie A Valkenburg; Karen Laurie; Yu Chih Liu; Justin T Denholm; Michael J Richards; Guus F Rimmelzwaan; Anne Kelso; Peter C Doherty; Stephen J Turner; Jamie Rossjohn; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 6.  Extracorporeal life support for pandemic influenza: the role of extracorporeal membrane oxygenation in pandemic management.

Authors:  Ed DeLaney; Michael J Smith; Brian T Harvey; Keith J Pelletier; Michael P Aquino; Justin M Stone; Gerald C Jean-Baptiste; Julie H Johnson
Journal:  J Extra Corpor Technol       Date:  2010-12

7.  Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients.

Authors:  Per Ljungman; Rafael de la Camara; Lena Perez-Bercoff; Manuel Abecasis; Jose Bartolo Nieto Campuzano; M Jimena Cannata-Ortiz; Catherine Cordonnier; Hermann Einsele; Marta Gonzalez-Vicent; Ildefonso Espigado; Jörg Halter; Rodrigo Martino; Bilal Mohty; Gülsan Sucak; Andrew J Ullmann; Lourdes Vázquez; Katherine N Ward; Dan Engelhard
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

8.  Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).

Authors:  J S Nguyen-Van-Tam; P J M Openshaw; A Hashim; E M Gadd; W S Lim; M G Semple; R C Read; B L Taylor; S J Brett; J McMenamin; J E Enstone; C Armstrong; K G Nicholson
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

9.  Influenza A (H1N1) in Victoria, Australia: a community case series and analysis of household transmission.

Authors:  Clare Looker; Kylie Carville; Kristina Grant; Heath Kelly
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

10.  Hospitalized adult patients with 2009 influenza A(H1N1) in Beijing, China: risk factors for hospital mortality.

Authors:  Xiuming Xi; Yuan Xu; Li Jiang; Ang Li; Jie Duan; Bin Du
Journal:  BMC Infect Dis       Date:  2010-08-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.